Skip to main content
NCBI home page
Gut logoLink to Gut
. 1998 Feb;42(2):175–179. doi: 10.1136/gut.42.2.175

General and cancer specific mortality of a population based cohort of patients with inflammatory bowel disease: the Florence study

D Palli 1, G Trallori 1, C Saieva 1, O Tarantino 1, E Edili 1, G D'Albasio 1, F Pacini 1, G Masala 1
PMCID: PMC1726997  PMID: 9536940

Abstract

Background—A population based epidemiological study identified all the patients diagnosed with ulcerative colitis (UC) or Crohn's disease (CD) resident in the Florence area in the period 1978-1992. 
Aims—To assess the mortality of unselected patients with inflammatory bowel disease (IBD) in a Mediterranean country. 
Methods—Overall, 920 patients (689 UC and 231 CD) were followed until death or end of follow up (31 December 1996). Information on vital status was available for all except eight patients (0.9%); 70 deaths were identified (23 in patients with CD and 47 in patients with UC). Expected deaths were estimated on the basis of five year age group, gender, and calendar year national mortality rates. Standardised mortality ratios (SMR) and 95% confidence intervals were calculated. 
Results—General mortality was significantly lower than expected in UC (SMR 0.6; 95% confidence interval 0.4 to 0.8), due to a reduced number of cardiovascular and, possibly, smoking related deaths. Cancers of the respiratory tract were significantly reduced in UC but tended to be increased in patients with CD. These latter patients had not only an increased cancer mortality but also a 40% increased risk of dying for all causes already evident in the first five year follow up period and persisting thereafter. In contrast, in patients with UC, SMRs were initially very low but tended to increase steadily over the follow up period. Gastrointestinal deaths were particularly increased in patients with CD, but only moderately in those with UC. Overall, there was some evidence of a twofold increased mortality for colorectal cancer, the risk being highest for rectal cancers in patients with UC. A non-significant excess of deaths due to haemolymphopoietic malignancies and suicides was also observed. 
Conclusions—This study, the first in a Mediterranean country, supports the existence of two divergent mortality patterns for patients with UC and CD, possibly explained by differences in smoking habits and by a greater severity of CD. 



Keywords: ulcerative colitis; Crohn's disease; inflammatory bowel disease; epidemiology; mortality; cancer

Full Text

The Full Text of this article is available as a PDF (104.2 KB).

Figure 1 .

Figure 1

Open in a new tab

Total mortality SMRs for each five year follow up period by IBD type. 


Figure 2 .

Figure 2

Open in a new tab

Kaplan-Meier survival curves of 796 incident patients with IBD by disease type. 


Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Broström O., Monsén U., Nordenwall B., Sörstad J., Hellers G. Prognosis and mortality of ulcerative colitis in Stockholm County, 1955-1979. Scand J Gastroenterol. 1987 Oct;22(8):907–913. doi: 10.3109/00365528708991934. [DOI] [PubMed] [Google Scholar]
  2. Cottone M., Magliocco A., Rosselli M., Pinzone F., Oliva L., Orlando A., Aiala M. R., Cipolla C., Pagliaro L. Mortality in patients with Crohn's disease. Scand J Gastroenterol. 1996 Apr;31(4):372–375. doi: 10.3109/00365529609006413. [DOI] [PubMed] [Google Scholar]
  3. Cottone M., Rosselli M., Orlando A., Oliva L., Puleo A., Cappello M., Traina M., Tonelli F., Pagliaro L. Smoking habits and recurrence in Crohn's disease. Gastroenterology. 1994 Mar;106(3):643–648. doi: 10.1016/0016-5085(94)90697-1. [DOI] [PubMed] [Google Scholar]
  4. Ekbom A., Helmick C. G., Zack M., Holmberg L., Adami H. O. Survival and causes of death in patients with inflammatory bowel disease: a population-based study. Gastroenterology. 1992 Sep;103(3):954–960. doi: 10.1016/0016-5085(92)90029-x. [DOI] [PubMed] [Google Scholar]
  5. Ekbom A., Helmick C., Zack M., Adami H. O. Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med. 1990 Nov 1;323(18):1228–1233. doi: 10.1056/NEJM199011013231802. [DOI] [PubMed] [Google Scholar]
  6. Franceschi S., Panza E., La Vecchia C., Parazzini F., Decarli A., Bianchi Porro G. Nonspecific inflammatory bowel disease and smoking. Am J Epidemiol. 1987 Mar;125(3):445–452. doi: 10.1093/oxfordjournals.aje.a114550. [DOI] [PubMed] [Google Scholar]
  7. Gillen C. D., Walmsley R. S., Prior P., Andrews H. A., Allan R. N. Ulcerative colitis and Crohn's disease: a comparison of the colorectal cancer risk in extensive colitis. Gut. 1994 Nov;35(11):1590–1592. doi: 10.1136/gut.35.11.1590. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gyde S. N., Prior P., Allan R. N., Stevens A., Jewell D. P., Truelove S. C., Lofberg R., Brostrom O., Hellers G. Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centres. Gut. 1988 Feb;29(2):206–217. doi: 10.1136/gut.29.2.206. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Kvist N., Jacobsen O., Kvist H. K., Nørgaard P., Ockelmann H. H., Schou G., Jarnum S. Malignancy in ulcerative colitis. Scand J Gastroenterol. 1989 May;24(4):497–506. doi: 10.3109/00365528909093080. [DOI] [PubMed] [Google Scholar]
  10. Langholz E., Munkholm P., Davidsen M., Binder V. Colorectal cancer risk and mortality in patients with ulcerative colitis. Gastroenterology. 1992 Nov;103(5):1444–1451. doi: 10.1016/0016-5085(92)91163-x. [DOI] [PubMed] [Google Scholar]
  11. Mellemkjaer L., Olsen J. H., Frisch M., Johansen C., Gridley G., McLaughlin J. K. Cancer in patients with ulcerative colitis. Int J Cancer. 1995 Jan 27;60(3):330–333. doi: 10.1002/ijc.2910600309. [DOI] [PubMed] [Google Scholar]
  12. Munkholm P., Langholz E., Davidsen M., Binder V. Intestinal cancer risk and mortality in patients with Crohn's disease. Gastroenterology. 1993 Dec;105(6):1716–1723. doi: 10.1016/0016-5085(93)91068-s. [DOI] [PubMed] [Google Scholar]
  13. Palli D., Masala G., Saieva C. Population-based studies of IBD incidence in Italy and capture-recapture methods. Int J Epidemiol. 1997 Aug;26(4):904–906. doi: 10.1093/ije/26.4.904b. [DOI] [PubMed] [Google Scholar]
  14. Persson P. G., Bernell O., Leijonmarck C. E., Farahmand B. Y., Hellers G., Ahlbom A. Survival and cause-specific mortality in inflammatory bowel disease: a population-based cohort study. Gastroenterology. 1996 May;110(5):1339–1345. doi: 10.1053/gast.1996.v110.pm8613037. [DOI] [PubMed] [Google Scholar]
  15. Persson P. G., Karlén P., Bernell O., Leijonmarck C. E., Broström O., Ahlbom A., Hellers G. Crohn's disease and cancer: a population-based cohort study. Gastroenterology. 1994 Dec;107(6):1675–1679. doi: 10.1016/0016-5085(94)90807-9. [DOI] [PubMed] [Google Scholar]
  16. Pinczowski D., Ekbom A., Baron J., Yuen J., Adami H. O. Risk factors for colorectal cancer in patients with ulcerative colitis: a case-control study. Gastroenterology. 1994 Jul;107(1):117–120. doi: 10.1016/0016-5085(94)90068-x. [DOI] [PubMed] [Google Scholar]
  17. Prior P., Gyde S. N., Macartney J. C., Thompson H., Waterhouse J. A., Allan R. N. Cancer morbidity in ulcerative colitis. Gut. 1982 Jun;23(6):490–497. doi: 10.1136/gut.23.6.490. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Prior P., Gyde S., Cooke W. T., Waterhouse J. A., Allan R. N. Mortality in Crohn's disease. Gastroenterology. 1981 Feb;80(2):307–312. [PubMed] [Google Scholar]
  19. Probert C. S., Jayanthi V., Wicks A. C., Mayberry J. F. Mortality from Crohn's disease in Leicestershire, 1972-1989: an epidemiological community based study. Gut. 1992 Sep;33(9):1226–1228. doi: 10.1136/gut.33.9.1226. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Probert C. S., Jayanthi V., Wicks A. C., Mayberry J. F. Mortality in patients with ulcerative colitis in Leicestershire, 1972-1989. An epidemiological study. Dig Dis Sci. 1993 Mar;38(3):538–541. doi: 10.1007/BF01316511. [DOI] [PubMed] [Google Scholar]
  21. Russel M. G., Stockbrügger R. W. Epidemiology of inflammatory bowel disease: an update. Scand J Gastroenterol. 1996 May;31(5):417–427. doi: 10.3109/00365529609006759. [DOI] [PubMed] [Google Scholar]
  22. Stewénius J., Adnerhill I., Anderson H., Ekelund G. R., Florén C. H., Fork F. T., Janzon L., Lindström C., Ogren M. Incidence of colorectal cancer and all cause mortality in non-selected patients with ulcerative colitis and indeterminate colitis in Malmö, Sweden. Int J Colorectal Dis. 1995;10(2):117–122. doi: 10.1007/BF00341210. [DOI] [PubMed] [Google Scholar]
  23. Tobin M. V., Logan R. F., Langman M. J., McConnell R. B., Gilmore I. T. Cigarette smoking and inflammatory bowel disease. Gastroenterology. 1987 Aug;93(2):316–321. doi: 10.1016/0016-5085(87)91021-3. [DOI] [PubMed] [Google Scholar]
  24. Trallori G., Palli D., Saieva C., Bardazzi G., Bonanomi A. G., d'Albasio G., Galli M., Vannozzi G., Milla M., Tarantino O. A population-based study of inflammatory bowel disease in Florence over 15 years (1978-92). Scand J Gastroenterol. 1996 Sep;31(9):892–899. doi: 10.3109/00365529609051998. [DOI] [PubMed] [Google Scholar]
  25. Weterman I. T., Biemond I., Peña A. S. Mortality and causes of death in Crohn's disease. Review of 50 years' experience in Leiden University Hospital. Gut. 1990 Dec;31(12):1387–1390. doi: 10.1136/gut.31.12.1387. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES